These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Is the decreasing availability of vecuronium and pancuronium putting patients at risk? Church HL; Kong KL; North J Eur J Anaesthesiol; 2009 Apr; 26(4):347-8. PubMed ID: 19401668 [No Abstract] [Full Text] [Related]
25. Vecuronium and bradycardia. May JR Anaesthesia; 1985 Jul; 40(7):710. PubMed ID: 2862809 [No Abstract] [Full Text] [Related]
26. Which formulation of propofol was used? Matsumura JS Anesthesiology; 2002 Jun; 96(6):1529; author reply 1529-30. PubMed ID: 12170076 [No Abstract] [Full Text] [Related]
27. Rapacuronium and the risk of bronchospasm in pediatric patients. Rajchert DM; Pasquariello CA; Watcha MF; Schreiner MS Anesth Analg; 2002 Mar; 94(3):488-93; table of contents. PubMed ID: 11867363 [TBL] [Abstract][Full Text] [Related]
28. Adverse effects of neuromuscular blockers and their antagonists. Naguib M; Magboul MM Middle East J Anaesthesiol; 1998 Jun; 14(5):341-73. PubMed ID: 9785339 [TBL] [Abstract][Full Text] [Related]
29. Histaminoid responses to atracurium, vecuronium and tubocurarine. Lavery GG; Clarke RS; Watkins J Ann Fr Anesth Reanim; 1985; 4(2):180-3. PubMed ID: 2408513 [TBL] [Abstract][Full Text] [Related]
31. Persistent paralysis after vecuronium administration. Conway EE N Engl J Med; 1992 Dec; 327(26):1882. PubMed ID: 1360147 [No Abstract] [Full Text] [Related]
32. Severe bronchospasm following the use of atracurium in children. Woods I; Morris P; Meakin G Anaesthesia; 1985 Feb; 40(2):207-8. PubMed ID: 3838421 [No Abstract] [Full Text] [Related]
34. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"? Spoerl D; Nigolian H; Czarnetzki C; Harr T Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439 [TBL] [Abstract][Full Text] [Related]
35. Rapacuronium: why did it fail as a replacement for succinylcholine? White PF Br J Anaesth; 2002 Feb; 88(2):163-5. PubMed ID: 11878650 [No Abstract] [Full Text] [Related]
36. Rapacuronium: premarket drug evaluation can be very effective for the identification of drug risks. Lim R Anesth Analg; 2003 Feb; 96(2):631-2. PubMed ID: 12538231 [No Abstract] [Full Text] [Related]
37. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Sadleir PH; Clarke RC; Bunning DL; Platt PR Br J Anaesth; 2013 Jun; 110(6):981-7. PubMed ID: 23335568 [TBL] [Abstract][Full Text] [Related]